SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-13-000084
Filing Date
2013-07-19
Accepted
2013-07-19 17:22:41
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ljpc-10q_20130630.htm 10-Q 363552
2 EX-31.1 ljpc-ex31_2013062966.htm EX-31 16938
3 EX-32.1 ljpc-ex32_2013062967.htm EX-32 7128
  Complete submission text file 0001564590-13-000084.txt   3385216

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ljpc-20130630.xml EX-101.INS 251306
5 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20130630.xsd EX-101.SCH 20137
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ljpc-20130630_cal.xml EX-101.CAL 18558
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ljpc-20130630_def.xml EX-101.DEF 115883
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20130630_lab.xml EX-101.LAB 155896
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20130630_pre.xml EX-101.PRE 135439
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 13977698
SIC: 2836 Biological Products, (No Diagnostic Substances)